Inosine

From NuGOwiki

(Redirected from HMDB00195)
Jump to: navigation, search

The NuGOwiki Metabolite Database is a joint initiative of NuGO and HMDB

Taxonomy Navigation Box; search by

All Metabolites | Biochemical | Nutritional | Functional | Metabolic Pathways | Diseases | Phenotypes | Physiological Processes | Protein

Inosine
2D structure for Inosine
Chemical Name 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one
Chemical Formula C10H12N4O5
CAS Number 58-63-9
Chemical Information HMDB00195
Biochemical Taxonomy

  • Nucleosides

Functional Taxonomy Not Available
Nutritional Taxonomy Not Available
Metabolic Pathways

  • Nicotinate and Nicotinamide Metabolism
  • Purine Metabolism

Biofluid Location

  • Blood
  • Cellular Cytoplasm
  • Cerebrospinal Fluid (CSF)
  • Pericardial Effusion

Tissue Location

  • Erythrocyte
  • Fibroblasts
  • Intestine
  • Kidney
  • Nerves
  • Pancreas
  • Placenta
  • Platelet
  • Spleen
  • Testes
  • Brain

Normal Biofluid Concentrations

  • Blood: 0.05 +/- 0.01 uM
  • Blood: 0.604 (0.102-1.81) uM
  • Blood: 5.0 +/- 0.8 uM
  • Blood: 5.0 +/- 6.3 uM
  • Cellular Cytoplasm: 1 uM
  • Cerebrospinal Fluid (CSF): 0.6 (0.0-1.2) uM
  • Cerebrospinal Fluid (CSF): 0.64 +/- 0.35 uM
  • Pericardial Effusion: 0.347 (0.159 - 1.037) uM

Normal Tissue Concentrations Not Available
Diseases / Conditions Related to Nutrition

  • Acute and severe illness
  • Coronary Artery Disease
  • Degenerative disc disease
  • Patients with Canavan disease
  • Patients with Chronic Renal Failure

Other (Monogenic Disorders) Not Available
Abnormal Biofluid Concentrations

  • Blood (Acute and severe illness): 0.13 +/- 0.10 uM
  • Blood (Patients with Canavan disease): 0.68 +/- 0.47 umol/L
  • Blood (Patients with Chronic Renal Failure): 1.6 +/- 0.4 umol/L
  • Cerebrospinal Fluid (CSF) (Degenerative disc disease): 0.70 (0.60-0.80) uM
  • Pericardial Effusion (Coronary Artery Disease): 0.658 (0.321 - 1.331) uM

Abnormal Tissue Concentrations Not Available
Physiological Processes Not Available
Authors:
Affiliations:

Contents

Introduction

guidelines
A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed)

Biological Function

guidelines

Catabolism

guidelines

Diseases / Conditions Related to Nutrition

guidelines

  • Acute and severe illness
  • Coronary Artery Disease
  • Degenerative disc disease
  • Patients with Canavan disease
  • Patients with Chronic Renal Failure

Other (Monogenic) Disorders

guidelines


Nutritional Information

guidelines

Drivers for biological variation

guidelines

Vulnerable groups

guidelines

Other resources

guidelines

Links

guidelines